- DE EN
- About Us
- Study Participation
We are very happy if you want to actively support us in our research for the benefit of people with diabetes mellitus.
If you can imagine taking part in a study, please feel free to use the contact form below to get in touch with us without any obligation.
Information on study participation and how to become a study participant can be found here:
Measuring blood glucose is the basis of every diabetes therapy. Therefore it is of utmost importance that people with diabetes mellitus are able to measure their blood glucose correctly.
An information flyer showing the most common mistakes in doing and how to correctly perform a blood glucose measurement can be found here:
Skin reactions following the use of medical devices such as CGM-systems or insulin pumps are a very common problem of people with diabetes mellitus.
The medical terms and descriptions of such cutaneous reactions vary greatly though (Pleus et al. 2019) and a standardized acquisition would help to properly assess the occurrence and the severity level of cutaneous reactions. Additionally it would make it easier to draw conclusions on the triggering factors and take appropriate countermeasures to reduce cutaneous reactions of the affected persons in the future.
In order to facilitate a broad and standardised acquisition of skin reactions on medical devices in diabetes management, a standardized report form was developed by the IfDT together with the dermatologist Dr. Stefanie Kamann under involvement of the Arbeitsgemeinschaft Diabetes & Technologie der Deutschen Diabetes Gesellschaft e. V. (AGDT) (Freckmann et al. 2021).
The IfDT is accredited by the Deutschen Akkreditierungsstelle GmbH German Accreditation Agency (DAkks /ILAC) and recognised by the Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten (ZLG) as a test laboratory after DIN EN ISO/IEC 17025 and the guideline 98/79/EG for investigations after DIN EN ISO 15197.
Our certificates can be found here:
To improve the reader-friendliness of our website, we use the generic masculine. In the context of equal treatment, we would like to point out that the content of our website is aimed at all genders and does not contain any valuation.